Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.06B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.87B |
| 3 |
Apple
AAPL
|
+$1.03B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$747M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$730M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$930M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$598M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$524M |
| 4 |
TSMC
TSM
|
+$363M |
| 5 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.47% |
| 2 | Healthcare | 9.44% |
| 3 | Financials | 9.02% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5551
Skillsoft
SKIL
$72.1M
| $105K | ﹤0.01% |
2,863
+2,266
| +380% | +$156K |
|
5552
SeaStar Medical
ICU
$12.2M
| $104K | ﹤0.01% |
41
-805
| -95% | -$2.06M |
|
|
ML
5553
DELISTED
MoneyLion Inc.
ML
| $104K | ﹤0.01% |
3,887
+1,948
| +100% | +$89.3K |
|
|
NINE
5554
DELISTED
Nine Energy Service
NINE
| $103K | ﹤0.01% |
39,006
-12,058
| -24% | -$34K |
|
5555
Viking Therapeutics
VKTX
$3.88B
| $101K | ﹤0.01% |
37,035
-20,322
| -35% | -$66.6K |
|
5556
Korro Bio
KRRO
$175M
| $100K | ﹤0.01% |
1,119
-402
| -26% | -$40.8K |
|
|
FTVIU
5557
DELISTED
FinTech Acquisition Corp. VI Units
FTVIU
| $100K | ﹤0.01% |
10,055
| – | – |
|
|
RKLY
5558
DELISTED
Rockley Photonics Holdings Limited
RKLY
| $99K | ﹤0.01% |
139,938
+81,797
| +141% | +$140K |
|
|
LSEA
5559
DELISTED
Landsea Homes
LSEA
| $98K | ﹤0.01% |
20,484
+9,164
| +81% | +$59.8K |
|
5560
Nexa Resources
NEXA
$1.89B
| $98K | ﹤0.01% |
+19,085
| New | +$110K |
|
5561
SelectQuote
SLQT
$120M
| $98K | ﹤0.01% |
134,826
+6,469
| +5% | +$10.7K |
|
5562
Rapid Micro Biosystems
RPID
$104M
| $97K | ﹤0.01% |
29,941
-23,549
| -44% | -$91.4K |
|
|
ZENV
5563
DELISTED
Zenvia
ZENV
| $97K | ﹤0.01% |
60,000
-160,000
| -73% | -$326K |
|
5564
Palladyne AI
PDYN
$278M
| $97K | ﹤0.01% |
+7,248
| New | +$136K |
|
|
BGRY
5565
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $97K | ﹤0.01% |
56,843
+36,429
| +178% | +$72.7K |
|
|
OMGA
5566
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $96K | ﹤0.01% |
17,780
-1,796
| -9% | -$9.1K |
|
5567
Bakkt Inc
BKKT
$318M
| $95K | ﹤0.01% |
+1,664
| New | +$111K |
|
|
CNF
5568
CNFinance Holdings
CNF
$38.1M
| $95K | ﹤0.01% |
3,763
-29,498
| -89% | -$744K |
|
5569
Harvard Bioscience
HBIO
$27.9M
| $95K | ﹤0.01% |
3,714
-2,588
| -41% | -$85.6K |
|
5570
LSI Industries
LYTS
$913M
| $95K | ﹤0.01% |
+12,373
| New | +$86.2K |
|
5571
X4 Pharmaceuticals
XFOR
$393M
| $95K | ﹤0.01% |
+1,846
| New | +$63.8K |
|
5572
The Beachbody Company
BODI
$72.3M
| $95K | ﹤0.01% |
1,882
-290
| -13% | -$18.4K |
|
|
ATCX
5573
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $95K | ﹤0.01% |
14,226
+43
| +0.3% | +$308 |
|
|
BCEL
5574
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $94K | ﹤0.01% |
59,674
-26,522
| -31% | -$54.5K |
|
|
AUD
5575
DELISTED
Audacy, Inc.
AUD
| $94K | ﹤0.01% |
242,738
-100,919
| -29% | -$61K |
|
Similar funds
Goldman Sachs's Q3 2022 Portfolio in Review
As of Q3 2022, Goldman Sachs held 6,885 positions worth $396B, down 1.1% from $400B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs deployed $17.3B of net new capital in Q3 2022, opening 459 new positions and adding to 2,707 existing holdings. Its largest new stake was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $930M trimmed.
- Goldman Sachs's largest Q3 2022 buy was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
- Goldman Sachs added most to Visa in Q3 2022, an estimated $2.06B increase.
- Goldman Sachs's biggest Q3 2022 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $930M.
- Goldman Sachs fully exited Mandiant, Inc. Common Stock in Q3 2022, selling an estimated $236M.
- Goldman Sachs's ten largest holdings make up 18% of its $396B portfolio in Q3 2022.
- Goldman Sachs opened 459 new positions and closed 646 in Q3 2022.
- Goldman Sachs's portfolio value fell 1.1% quarter-over-quarter to $396B.
Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.